Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1864-6433
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease ; day:21 ; month:11 ; year:2022 ; pages:1-13
Annals of nuclear medicine ; (21.11.2022), 1-13

Creator
Ohnishi, Akihito
Akamatsu, Go
Ikari, Yasuhiko
Nishida, Hiroyuki
Shimizu, Keiji
Matsumoto, Keiichi
Aita, Kazuki
Sasaki, Masahiro
Yamamoto, Yasuji
Yamane, Tomohiko
Senda, Michio
Contributor
SpringerLink (Online service)

DOI
10.1007/s12149-022-01808-7
URN
urn:nbn:de:101:1-2023020221042264434695
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Ohnishi, Akihito
  • Akamatsu, Go
  • Ikari, Yasuhiko
  • Nishida, Hiroyuki
  • Shimizu, Keiji
  • Matsumoto, Keiichi
  • Aita, Kazuki
  • Sasaki, Masahiro
  • Yamamoto, Yasuji
  • Yamane, Tomohiko
  • Senda, Michio
  • SpringerLink (Online service)

Other Objects (12)

Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease

Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease

Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP

Human biodistribution and radiation dosimetry of the demyelination tracer [18F]3F4AP

Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease

Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451

Human biodistribution and radiation dosimetry for the tau tracer [18F]Florzolotau in healthy subjects

Human biodistribution and radiation dosimetry for the tau tracer [18F]Florzolotau in healthy subjects

Development, Characterization, and Radiation Dosimetry Studies of 18F-BMS-986229, a 18F-Labeled PD-L1 Macrocyclic Peptide PET Tracer

Development, Characterization, and Radiation Dosimetry Studies of 18F-BMS-986229, a 18F-Labeled PD-L1 Macrocyclic Peptide PET Tracer

Radiation dosimetry of para-chloro-2-[18F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging

Radiation dosimetry of para-chloro-2-[18F]fluoroethyl-etomidate: a PET tracer for adrenocortical imaging

Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects

Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects

Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease

Unsupervised [18F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

Alzheimer’s Disease Prediction Using Attention Mechanism with Dual-Phase 18F-Florbetaben Images

Alzheimer’s Disease Prediction Using Attention Mechanism with Dual-Phase 18F-Florbetaben Images

Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects

Correction: Radiation dosimetry and pharmacokinetics of the tau PET tracer florzolotau (18F) in healthy Japanese subjects

Related objects